scholarly journals Immune Profile of Mucosal-Associated Invariant T Cells in Chronic Viral Hepatitis: A Systematic Review and Meta-Analysis

2019 ◽  
Vol 19 (8) ◽  
Author(s):  
Qinling Liu ◽  
Feng Zhu ◽  
Yujing Shi ◽  
Dazhi Zhang
Keyword(s):  
Systematic Review ◽  
T Cells ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Meta Analysis ◽  
Chronic Viral Hepatitis ◽  
Immune Profile ◽  
Invariant T Cells ◽  
Viral Hepatitis A

scholarly journals Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants

2021 ◽  
Vol 53 (1) ◽  
pp. 1227-1242
Author(s):  
Amir Vahedian-Azimi ◽  
Sajad Shojaie ◽  
Maciej Banach ◽  
Farshad Heidari ◽  
Arrigo F. G. Cicero ◽  
...  
Keyword(s):  
Systematic Review ◽  
Viral Hepatitis ◽  
Statin Therapy ◽  
Hepatitis A ◽  
Meta Analysis ◽  
Chronic Viral Hepatitis ◽  
Viral Hepatitis A

scholarly journals Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses

2016 ◽  
Vol 16 (12) ◽  
pp. 1409-1422 ◽  
Author(s):  
Kali Zhou ◽  
Thomas Fitzpatrick ◽  
Nick Walsh ◽  
Ji Young Kim ◽  
Roger Chou ◽  
...  
Keyword(s):  
Systematic Review ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Chronic Viral Hepatitis ◽  
Care Continuum ◽  
Meta Analyses ◽  
Viral Hepatitis A

Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature

2013 ◽  
Vol 14 (18) ◽  
pp. 2533-2544 ◽  
Author(s):  
Ferdinando Fusco ◽  
Gianluca D'Anzeo ◽  
Andrea Rossi ◽  
Carmine Sciorio ◽  
Antonio Riccardo Buonomo ◽  
...  
Keyword(s):  
Systematic Review ◽  
Erectile Dysfunction ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Chronic Viral Hepatitis ◽  
Review Of The Literature ◽  
Viral Hepatitis A

scholarly journals Evaluation of hepatic fibrosis stage (≥ F2) by fibroscan in patients with chronic viral hepatitis: A Meta-analysis

2013 ◽  
Vol 21 (33) ◽  
pp. 3724
Author(s):  
Zi-Hua Luo ◽  
Jian Zou ◽  
Lin Mi ◽  
Yan Liu ◽  
Yi-Li Tong ◽  
...  
Keyword(s):  
Viral Hepatitis ◽  
Hepatic Fibrosis ◽  
Hepatitis A ◽  
Meta Analysis ◽  
Chronic Viral Hepatitis ◽  
Fibrosis Stage ◽  
Viral Hepatitis A

eHealth Technologies for Screening, Diagnosis, and Management of Viral Hepatitis: A Systematic Review

2020 ◽  
Author(s):  
James Haridy ◽  
Guru Iyngkaran ◽  
Amanda Nicoll ◽  
Geoffrey Hebbard ◽  
Edmund Tse ◽  
...  
Keyword(s):  
Systematic Review ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Diagnosis And Management ◽  
Viral Hepatitis A

History and Global Burden of Viral Hepatitis

2016 ◽  
Vol 34 (4) ◽  
pp. 293-302 ◽  
Author(s):  
Hubert E. Blum
Keyword(s):  
Liver Cirrhosis ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Hepatitis E ◽  
Chronic Viral Hepatitis ◽  
Global Burden ◽  
Disability Adjusted Life ◽  
Life Years ◽  
Viral Hepatitis A

Between 1963 and 1989, 5 hepatotropic viruses have been discovered that are the major causes of viral hepatitides worldwide: hepatitis A virus, hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis delta virus and hepatitis E virus. Their epidemiology and pathogenesis have been studied in great detail. Furthermore, the structure and genetic organization of their DNA or RNA genome including the viral life cycle have been elucidated and have been successfully translated into important clinical applications, such as the specific diagnosis, therapy and prevention of the associated liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic viral hepatitis A-E shows distinct geographic differences. The global burden of disease (prevalence, incidence, death, disability-adjusted life years) has been analyzed in seminal studies that show that the worldwide prevalence of hepatitis A-E has significantly decreased between 1990 and 2013. During the same time, the incidence of HBV-related liver cirrhosis and HCC, respectively, also decreased or increased slightly, the incidence of the HCV-related liver cirrhosis remained stable and the incidence of HCV-related HCC showed a major increase. During the coming years, we expect to improve our ability to prevent and effectively treat viral hepatitis A-E, resulting in the control of these global infections and the elimination of their associated morbidities and mortalities.

Sign in / Sign up

Export Citation Format

Share Document